Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations
- PMID: 17690122
- DOI: 10.1183/09031936.00050306
Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations
Abstract
The objective of the present study was to investigate the kinetics of high doses of inhaled steroid fluticasone in comparison with oral steroid prednisone on plasma protein leakage and bronchial eosinophilia in adults with moderate asthma exacerbations. The study design was a randomised, double-blind, placebo-controlled prospective trial. In total, 45 patients treated at the emergency department for moderate asthma exacerbations were recruited and 39 were assigned to receive fluticasone and placebo of prednisone (19 patients), or prednisone and placebo of fluticasone (20 patients). Medication was administered to all patients via a metered-dose inhaler and spacer (16 puffs; 4,000 microg.day(-1) or placebo) plus one pill (prednisone 30 mg.day(-1) or placebo). Spirometry and induced sputum for differential cell counts, albumin and alpha(2)-macroglobulin levels and blood eosinophils, interleukin-5 and granulocyte-macrophage colony-stimulating factor levels were obtained before treatment and at 2, 6 and 24 h after treatment. Symptoms clearly improved after 24 h in both groups. No differences were seen between groups in peak expiratory flow or forced expiratory flow in one second, which improved progressively but then decayed slightly after 24 h. Eosinophil counts in sputum also improved over time in both groups. The effect was faster with fluticasone than with prednisone, but was partially lost at 24 h. However, plasma proteins in sputum and eosinophil count in blood both decreased until 24 h, with no significant differences between groups. There was no correlation between eosinophil counts and plasmatic protein levels. In conclusion, both treatments improved symptoms, airway obstruction and inflammation, and plasma protein leakage at 24 h. Prednisone reduced blood eosinophil counts, while fluticasone reduced airway eosinophil counts, suggesting that the anti-inflammatory performance of fluticasone is exerted locally.
Comment in
-
The role of inhaled corticosteroids in the management of acute asthma.Eur Respir J. 2007 Dec;30(6):1035-7. doi: 10.1183/09031936.00119907. Eur Respir J. 2007. PMID: 18055700 No abstract available.
Similar articles
-
Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.Pulm Pharmacol Ther. 2006;19(5):353-60. doi: 10.1016/j.pupt.2005.09.003. Epub 2005 Nov 11. Pulm Pharmacol Ther. 2006. PMID: 16289980 Clinical Trial.
-
Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.Am J Respir Crit Care Med. 1999 Jul;160(1):93-9. doi: 10.1164/ajrccm.160.1.9809104. Am J Respir Crit Care Med. 1999. PMID: 10390385 Clinical Trial.
-
High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.Pediatrics. 2006 Aug;118(2):644-50. doi: 10.1542/peds.2005-2842. Pediatrics. 2006. PMID: 16882819 Clinical Trial.
-
Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.BioDrugs. 2001;15(4):239-49. doi: 10.2165/00063030-200115040-00004. BioDrugs. 2001. PMID: 11437689 Review.
-
Anti-inflammatory properties of fluticasone propionate.Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):439-40. doi: 10.1159/000237073. Int Arch Allergy Immunol. 1995. PMID: 7613206 Review. No abstract available.
Cited by
-
COVID-19 and COPD: lessons beyond the pandemic.Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L978-L982. doi: 10.1152/ajplung.00386.2021. Epub 2021 Sep 29. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34585618 Free PMC article.
-
Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: a randomized control trial.Med Sci Monit. 2014 Mar 28;20:513-20. doi: 10.12659/MSM.890210. Med Sci Monit. 2014. PMID: 24675102 Free PMC article. Clinical Trial.
-
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD007524. doi: 10.1002/14651858.CD007524.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2022 Sep 26;9:CD007524. doi: 10.1002/14651858.CD007524.pub5. PMID: 27272563 Free PMC article. Updated.
-
Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002308. doi: 10.1002/14651858.CD002308.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235589 Free PMC article.
-
The effect of inhaled corticosteroids on hypothalamic-pituitary-adrenal axis.Indian J Pharmacol. 2012 May;44(3):314-8. doi: 10.4103/0253-7613.96300. Indian J Pharmacol. 2012. PMID: 22701238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical